Vicapsys Life Sciences, Inc.

VICP · OTC · SIC 2834: Pharmaceutical Preparations
41
SEC Filings

Business Summary

Vicapsys Life Sciences, Inc. is a Florida-incorporated biopharmaceutical holding company developing encapsulated product candidates incorporating proprietary derivatives of the chemokine CXCL12 to create immunoprotection zones around cells, tissues, organs, and devices. Its lead product line VICAPSYN targets transplantation therapies including Type 1 Diabetes treatment via encapsulated human islet cell clusters. A second line, VYBRIN, addresses anti-fibrotic applications including post-surgical adhesion prevention, implantable device coating, and diabetic wound healing.

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionVICPdiscussed_in_filing Trusted Computing
topic_mentionVICPdiscussed_in_filing Blockchain & Crypto
topic_mentionVICPdiscussed_in_filing Regulation
topic_mentionVICPdiscussed_in_filing Healthcare & Bio
topic_mentionVICPdiscussed_in_filing Platform & Ecosystem
topic_mentionVICPdiscussed_in_filing Sovereign & Government
topic_mentionVICPdiscussed_in_filing Trusted Computing
topic_mentionVICPdiscussed_in_filing Blockchain & Crypto
topic_mentionVICPdiscussed_in_filing Regulation
topic_mentionVICPdiscussed_in_filing Healthcare & Bio
topic_mentionVICPdiscussed_in_filing Platform & Ecosystem
topic_mentionVICPdiscussed_in_filing Sovereign & Government
topic_mentionVICPdiscussed_in_filing Trusted Computing
topic_mentionVICPdiscussed_in_filing Blockchain & Crypto
topic_mentionVICPdiscussed_in_filing Regulation
topic_mentionVICPdiscussed_in_filing Healthcare & Bio
topic_mentionVICPdiscussed_in_filing Platform & Ecosystem
topic_mentionVICPdiscussed_in_filing Sovereign & Government
topic_mentionVICPdiscussed_in_filing Trusted Computing
topic_mentionVICPdiscussed_in_filing Blockchain & Crypto

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2024-10-212023-12-310001493152-24-041809EDGAR45K words
2023-04-142022-12-310001493152-23-012267EDGAR—
2022-03-162021-12-310001493152-22-006994EDGAR—
2021-09-172020-12-310001493152-21-022984EDGAR—
2010-05-242009-12-310001144204-10-029858EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-01-102024-09-300001493152-25-001779EDGAR16K words
2025-01-102024-06-300001493152-25-001776EDGAR—
2025-01-102024-03-310001493152-25-001743EDGAR—
2023-11-142023-09-300001493152-23-040951EDGAR—
2023-08-142023-06-300001493152-23-028151EDGAR—
2023-05-152023-03-310001493152-23-017138EDGAR—
2022-11-212022-09-300001493152-22-033024EDGAR—
2022-08-162022-06-300001493152-22-023207EDGAR—
2022-05-132022-03-310001493152-22-013375EDGAR—
2021-11-122021-09-300001493152-21-027976EDGAR—
2021-09-202021-06-300001493152-21-023189EDGAR—
2021-09-202021-03-310001493152-21-023170EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2023-12-270001493152-23-046217EDGAR1K words
2023-06-300001493152-23-023183EDGAR—
2023-06-020001493152-23-019905EDGAR—
2023-05-170001493152-23-017970EDGAR—
2023-01-120001493152-23-001296EDGAR—
2022-09-280001493152-22-027017EDGAR—
2022-04-120001493152-22-009690EDGAR—
2010-07-010001144204-10-036040EDGAR—
2010-05-180001144204-10-028744EDGAR—
2010-04-260001144204-10-022071EDGAR—

41 total filings indexed. 14 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Tags

type-1-diabetes-treatment transplantation-therapy post-surgical-adhesion-prevention implantable-medical-devices wound-healing-/-diabetic-ulcers fda-quality-system-regulations iso-13485

Company Identity

CIK0001468639
TickerVICP
ExchangeOTC
SIC2834: Pharmaceutical Preparations
IncorporatedFL

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: d07921c9874fecbe2a797f070ae6c47d81f9a6bd3df777c65c4d0018d665227f
parent: d37510f9ace872f03f0c2e68a2aa1d465000a98990f40f24bda157bd175fd39c
content hash: 8d1095a435721091f72e9142164b2b3299b38bc8f2f87b4a0e7d5167390b7be8
signed: 2026-04-13T04:48:05.278Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf